Daptomycin Lactone Open Ring Impurity - Solicitar cotización

Daptomycin Lactone Open Ring Impurity is chemically (2S,5S,8R,14S,17R,20S,23S,29S,32S)-32-((R)-4-Amino-2-((S)-2-decanamido-3-(1H-indol-3-yl)propanamido)-4-oxobutanamido)-2-(2-(2-aminophenyl)-2-oxoethyl)-23-(3-aminopropyl)-14,20-bis(carboxymethyl)-5-((S)-1-carboxypropan-2-yl)-29-((R)-1-hydroxyethyl)-8-(hydroxymethyl)-17-methyl-4,7,10,13,16,19,22,25,28,31-decaoxo-3,6,9,12,15,18,21,24,27,30-decaazatetratriacontanedioic acid. Daptomycin Lactone Open Ring Impurity is supplied with detailed characterization data compliant with regulatory guideline. Daptomycin Lactone Open Ring Impurity can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Daptomycin.

The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.